{"status":"OK","data":{"advertisement":{"id":260097,"title":"17/2024 \u2013 RNA: Us\u0142uga analizy strukturalnej oddzia\u0142ywa\u0144 kompleksu fragment\u00f3w mRNA (maksymalnie 4 r\u00f3\u017cne mRNA, dla ka\u017cdego maksymalnie 3 r\u00f3\u017cne konstrukty) z maksymalnie dwoma (2) ma\u0142ocz\u0105steczkowymi ligandami.","partial_offer_allowed":false,"publication_date":"2024-09-02","submission_deadline":"2024-09-05 23:59:59","planned_sign_date":null,"supplementary_orders":"nie dotyczy","terms_of_contract_change":"Zgodnie z za\u0142\u0105czonym Zaproszeniem do sk\u0142adania ofert","created_at":"2024-09-02 10:18:03","modified_at":"2024-09-06 00:00:12","contact_persons":[{"id":50393,"forename":"\u0141ukasz ","surname":"M\u0105kolski","phone_number":"518 095 618","email":"l.makolski@molecure.com","created_by":null,"created_at":"2026-10-19 14:01:01","modified_at":"2026-10-19 14:01:01","modified_by":null},{"id":65974,"forename":"Katherine","surname":"Burchiellaro","phone_number":"","email":"k.burchiellaro@molecure.com","created_by":null,"created_at":"2024-09-02 10:18:03","modified_at":"2024-09-02 10:18:03","modified_by":null}],"orders":[{"id":421594,"estimated_value":null,"order_items":[{"id":475284,"description":"Us\u0142uga analizy strukturalnej oddzia\u0142ywa\u0144 kompleksu fragment\u00f3w mRNA (maksymalnie 4 r\u00f3\u017cne mRNA, dla ka\u017cdego maksymalnie 3 r\u00f3\u017cne konstrukty) z maksymalnie dwoma (2) ma\u0142ocz\u0105steczkowymi ligandami.","warranty_period":null,"cpv_items":[{"id":8515,"code":"73111000-3","name":"Laboratoryjne us\u0142ugi badawcze"}],"timetable_items":[],"fulfillment_places":[{"country":"Polska","voivodeship":"mazowieckie","poviat":"Warszawa","commune":"Ochota","locality":"Warszawa","created_by":null,"created_at":"2024-09-02 10:18:03","modified_at":"2024-09-02 10:18:05","modified_by":null,"id":534538,"type":{"id":1,"name":"adres"},"group_uuid":"65f8193a-f598-4a81-a296-c3a160dd7e06"}],"participation_conditions":[{"id":1310063,"description":"Zapytanie ofertowe dotyczy potencjalnych wykonawc\u00f3w prowadz\u0105cych dzia\u0142alno\u015b\u0107 w pe\u0142ni zgodn\u0105 z opisem przedmiotu zam\u00f3wienia.","type":{"id":1,"name":"Uprawnienia do wykonywania okre\u015blonej dzia\u0142alno\u015bci lub czynno\u015bci"},"created_by":null,"created_at":"2024-09-02 10:18:03","modified_at":"2024-09-02 10:18:03","modified_by":null,"group_uuid":"63a823cc-9697-409e-a261-750db9010c74"},{"id":1310064,"description":"Oferty mog\u0105 by\u0107 sk\u0142adane przez Oferent\u00f3w, kt\u00f3rzy posiadaj\u0105 wiedz\u0119 i do\u015bwiadczenie niezb\u0119dne do wykonania zam\u00f3wienia.","type":{"id":2,"name":"Wiedza i do\u015bwiadczenie"},"created_by":null,"created_at":"2024-09-02 10:18:03","modified_at":"2024-09-02 10:18:03","modified_by":null,"group_uuid":"ca3d0cd0-22c6-4337-b4c9-be28ab7ec1c9"},{"id":1310065,"description":"Oferty mog\u0105 by\u0107 sk\u0142adane przez Oferent\u00f3w, kt\u00f3rzy posiadaj\u0105 odpowiedni potencja\u0142 kadrowy, zdolny do wykonania zam\u00f3wienia, w szczeg\u00f3lno\u015bci dysponuj\u0105 zespo\u0142em z do\u015bwiadczeniem w krystalizacji i syntezie RNA, przeprowadzaniu pomiar\u00f3w synchrotronowych oraz przetwarzaniu danych dyfrakcyjnych. Zesp\u00f3\u0142 Oferenta powinien wykaza\u0107 si\u0119 co najmniej 7 publikacjami w dziedzinie krystalizacji w recenzowanych czasopismach naukowych.","type":{"id":4,"name":"Osoby zdolne do wykonania zam\u00f3wienia"},"created_by":null,"created_at":"2024-09-02 10:18:03","modified_at":"2024-09-02 10:18:03","modified_by":null,"group_uuid":"5e484171-0bf4-4d7e-9c7d-e623ea4aa140"},{"id":1310066,"description":"Oferty mog\u0105 by\u0107 sk\u0142adane przez Oferent\u00f3w, kt\u00f3rzy dysponuj\u0105 potencja\u0142em technicznym do wykonania zam\u00f3wienia, w tym posiadaj\u0105 swobodny dost\u0119p do dyfraktometru.","type":{"id":3,"name":"Potencja\u0142 techniczny"},"created_by":null,"created_at":"2024-09-02 10:18:03","modified_at":"2024-09-02 10:18:03","modified_by":null,"group_uuid":"ec489889-e7f0-48b1-a219-8dee26ebb140"},{"id":1310067,"description":"Oferty mog\u0105 by\u0107 sk\u0142adane przez Oferent\u00f3w, kt\u00f3rzy znajduj\u0105 si\u0119 w dobrej sytuacji ekonomicznej i finansowej, kt\u00f3ra zapewni w\u0142a\u015bciw\u0105 realizacj\u0119 zam\u00f3wienia.","type":{"id":5,"name":"Sytuacja ekonomiczna i finansowa"},"created_by":null,"created_at":"2024-09-02 10:18:03","modified_at":"2024-09-02 10:18:03","modified_by":null,"group_uuid":"e9167d51-9f85-43f8-9a9b-7be5642136f6"},{"id":1310068,"description":"Oferty mog\u0105 by\u0107 sk\u0142adane przez Oferent\u00f3w, kt\u00f3rzy d\u0105\u017cy\u0107 b\u0119d\u0105 do realizacji zam\u00f3wienia w spos\u00f3b korzystny dla \u015brodowiska, poprzez zapewnienie minimalizacji zu\u017cycia materia\u0142\u00f3w, surowc\u00f3w, energii.\n\nOferent powi\u0105zany z Zamawiaj\u0105cym osobowo lub kapita\u0142owo podlega wykluczeniu z post\u0119powania. Przez powi\u0105zania kapita\u0142owe lub osobowe rozumie si\u0119 wzajemne powi\u0105zania mi\u0119dzy Zamawiaj\u0105cym lub osobami upowa\u017cnionymi do zaci\u0105gania zobowi\u0105za\u0144 w imieniu Zamawiaj\u0105cego lub osobami wykonuj\u0105cymi w imieniu Zamawiaj\u0105cego czynno\u015bci zwi\u0105zane z przygotowaniem i przeprowadzeniem procedury wyboru Oferenta a Oferentem, polegaj\u0105ce w szczeg\u00f3lno\u015bci na:\nA)\tuczestniczeniu w sp\u00f3\u0142ce jako wsp\u00f3lnik sp\u00f3\u0142ki cywilnej lub sp\u00f3\u0142ki osobowej, posiadaniu co najmniej 10% udzia\u0142\u00f3w lub akcji (o ile ni\u017cszy pr\u00f3g nie wynika z przepis\u00f3w prawa), pe\u0142nieniu funkcji cz\u0142onka organu nadzorczego lub zarz\u0105dzaj\u0105cego, prokurenta, pe\u0142nomocnika;\nB)\tpozostawaniu w zwi\u0105zku ma\u0142\u017ce\u0144skim, w stosunku pokrewie\u0144stwa lub powinowactwa w linii prostej, pokrewie\u0144stwa lub powinowactwa w linii bocznej do drugiego stopnia, lub zwi\u0105zaniu z tytu\u0142u przysposobienia, opieki lub kurateli albo pozostawaniu we wsp\u00f3lnym po\u017cyciu z Oferentem, jego zast\u0119pc\u0105 prawnym lub cz\u0142onkami organ\u00f3w zarz\u0105dzaj\u0105cych lub organ\u00f3w nadzorczych Oferent\u00f3w ubiegaj\u0105cych si\u0119 o udzielenie zam\u00f3wienia;\nC)\tpozostawaniu z Oferentem w takim stosunku prawnym lub faktycznym, \u017ce istnieje uzasadniona w\u0105tpliwo\u015b\u0107 co do ich bezstronno\u015bci lub niezale\u017cno\u015bci w zwi\u0105zku z post\u0119powaniem o udzielenie zam\u00f3wienia.","type":{"id":7,"name":"Dodatkowe warunki udzia\u0142u"},"created_by":null,"created_at":"2024-09-02 10:18:03","modified_at":"2024-09-02 10:18:03","modified_by":null,"group_uuid":"38be681e-48bb-493f-8931-dc443ecd8b16"},{"id":1310069,"description":"Za\u0142\u0105cznik nr 1 Wz\u00f3r formularza ofertowego\nZa\u0142\u0105cznik nr 2 O\u015bwiadczenie potwierdzaj\u0105ce spe\u0142nienie warunk\u00f3w udzia\u0142u\nZa\u0142\u0105cznik nr 3 O\u015bwiadczenie w przedmiocie powi\u0105za\u0144 osobowych i kapita\u0142owych z Zamawiaj\u0105cym\nZa\u0142\u0105cznik nr 4 Deklaracja zgodno\u015bci z obowi\u0105zkami informacyjnymi okre\u015blonymi w art. 13 lub art. 14 RODO\nZa\u0142\u0105cznik nr 5 O\u015bwiadczenie dotycz\u0105ce obj\u0119cia sankcjami\nZa\u0142\u0105cznik nr 6 Umowa o zachowaniu Poufno\u015bci","type":{"id":6,"name":"Lista wymaganych dokument\u00f3w/o\u015bwiadcze\u0144"},"created_by":null,"created_at":"2024-09-02 10:18:03","modified_at":"2024-09-02 10:18:03","modified_by":null,"group_uuid":"5c794ba0-a247-4202-bca6-b3f699a422cc"}],"category":{"id":1,"name":"Us\u0142uga"},"subcategory":{"id":4,"name":"Us\u0142ugi badawcze"},"created_by":null,"created_at":"2024-09-02 10:18:03","modified_at":"2024-09-02 10:18:05","modified_by":null,"group_uuid":"7ecdfff3-4ebb-4e16-9380-5459122fb7e6"}],"evaluation_criteria":[{"id":729559,"price_criterion":true,"description":"Ca\u0142kowita cena netto - Waga: 100% (100 pkt)\nW kryterium tym punkty zostan\u0105 przyznane zgodnie ze wzorem zamieszczonym w Zapytaniu (Zaproszeniu do sk\u0142adania ofert).","created_by":null,"created_at":"2024-09-02 10:18:03","modified_at":"2024-09-02 10:18:03","modified_by":null,"group_uuid":"4f1819bc-83c2-4e8e-a4ea-8b22b4473d34"}],"is_variant":false,"title":"Us\u0142uga analizy strukturalnej oddzia\u0142ywania RNA z ligandami","order_node":{"id":317833},"created_by":null,"created_at":"2024-09-02 10:18:03","modified_at":"2024-09-02 10:18:05","modified_by":null}],"created_by":{"id":40929,"contact_persons":[]},"modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":2,"label":"PUBLISHED","name":"Opublikowane"},"advertiser_address_details":{"name":"MOLECURE SA","identification_number_type":"nip","identification_number":"7282789248","address":{"country":"Polska","voivodeship":"mazowieckie","poviat":"Warszawa","commune":"Ochota","locality":"Warszawa","created_by":{"id":40929,"contact_persons":[]},"created_at":"2024-09-02 10:18:03","modified_at":"2024-09-02 10:18:03","modified_by":{"id":40929,"contact_persons":[]},"id":704032,"street":"\u017bwirki i Wigury","number_description":"101","postcode":"02-089"},"created_by":{"id":40929,"contact_persons":[]},"created_at":"2024-09-02 10:18:03","modified_at":"2024-09-02 10:18:03","modified_by":{"id":40929,"contact_persons":[]},"id":260673},"advertisement":{"id":196527,"number":"2024-40929-196527","publication_date":"2024-08-20","created_by":{"id":40929,"contact_persons":[]},"created_at":"2024-08-20 14:23:52","modified_at":"2024-09-06 00:00:12","modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":6,"label":"RESOLVED","name":"Rozstrzygni\u0119te"},"all_available_version_ids":[258811,260023,260097],"enrollment":null,"projects":[{"id":43740,"name":"Prze\u0142omowa us\u0142uga odkrywania nowych lek\u00f3w ma\u0142ocz\u0105steczkowych celuj\u0105cych w mRNA dla nieuleczalnych chor\u00f3b","number":"1256/23","activity":{"created_by":{"modified_by":null,"id":89,"contact_persons":[]},"created_at":"2023-02-01 09:22:25","modified_at":"2023-02-01 09:22:25","modified_by":{"modified_by":null,"id":89,"contact_persons":[]}},"region":null,"institution":{"created_by":{"modified_by":null,"id":89,"contact_persons":[]},"created_at":"2023-02-01 09:28:01","modified_at":"2023-02-01 09:28:01","modified_by":{"modified_by":null,"id":89,"contact_persons":[]}},"full_number":"FENG.01.01-IP.02-1256/23","perspective":{},"programme":{"created_by":{"modified_by":null,"id":89,"contact_persons":[]},"created_at":"2023-02-01 09:21:41","modified_at":"2023-02-01 09:21:41","modified_by":{"modified_by":null,"id":89,"contact_persons":[]}},"priority":{"created_by":{"modified_by":null,"id":89,"contact_persons":[]},"created_at":"2023-02-01 09:21:51","modified_at":"2023-02-01 09:21:51","modified_by":{"modified_by":null,"id":89,"contact_persons":[]}},"type":"project","created_by":{"id":40929,"contact_persons":[]},"created_at":"2024-01-31 12:57:17","modified_at":"2024-01-31 12:57:17","modified_by":{"id":40929,"contact_persons":[]}}],"is_author":false,"is_admin":false},"attachments":[{"origin":{"id":258811,"publication_date":"2024-08-20"},"id":1398798,"name":"17_2024_Zapytanie_kryst_RNA","file":{"id":1560558,"name":"17_2024_Zapytanie_kryst_RNA.pdf","created_at":"2024-09-02 10:18:03","created_by":{"forename":"Karolina","surname":"K\u0119dzierska"},"uri":"/api/files/1560558"},"group_uuid":"11683de1-61b1-4940-b312-1c91c0aef8af"},{"origin":{"id":258811,"publication_date":"2024-08-20"},"id":1398799,"name":"17_2024_Za\u0142\u0105czniki 1_2_3_4_5","file":{"id":1560560,"name":"17_2024_Za\u0142\u0105czniki 1_2_3_4_5.docx","created_at":"2024-09-02 10:18:03","created_by":{"forename":"Karolina","surname":"K\u0119dzierska"},"uri":"/api/files/1560560"},"group_uuid":"7e992a3a-9179-4db1-943e-d7cb495698a4"},{"origin":{"id":258811,"publication_date":"2024-08-20"},"id":1398800,"name":"17_2024_Zalacznik 6","file":{"id":1560565,"name":"17_2024_Zalacznik 6.docx","created_at":"2024-09-02 10:18:03","created_by":{"forename":"Karolina","surname":"K\u0119dzierska"},"uri":"/api/files/1560565"},"group_uuid":"6cdee0e8-e05f-40d0-9d1b-d32feb6cb79e"},{"origin":{"id":260023,"publication_date":"2024-08-30"},"id":1410671,"name":"17_2024_Zalacznik 6_aktualizacja 30.08","file":{"id":1573820,"name":"17_2024_Zalacznik 6_aktualizacja 30.08.docx","created_at":"2024-09-02 10:18:03","created_by":{"forename":"Karolina","surname":"K\u0119dzierska"},"uri":"/api/files/1573820"},"group_uuid":"590a03f8-d4db-4c20-b51e-bcec59d1435c"},{"origin":{"id":260097,"publication_date":"2024-09-02"},"id":1411582,"name":"17_2024_Zapytanie_kryst_RNA_aktualizacja 02.09","file":{"id":1574813,"name":"17_2024_Zapytanie_kryst_RNA_aktualizacja 02.09.pdf","created_at":"2024-09-02 10:17:50","created_by":{"forename":"Karolina","surname":"K\u0119dzierska"},"uri":"/api/files/1574813"},"group_uuid":"800df17a-2da9-4a71-bed1-8a7a9cf47e0a"}]},"dictionaries":{"announcement_status_draft":1,"announcement_status_published":2},"favorite":null,"badge":null,"offer_set_badge_count":null,"question_badge_count":null}}